You are here
Secondary to long term eye therapy with topically applied drugs or solutions
Conjunctivitis - Secondary to long term eye therapy with topically applied drugs or solutions Factor
Last reviewed for CCPS 27 September 1999.
Preliminary questions [10004]
10076 there is some evidence that long term eye therapy with topically applied drugs or solutions may be a factor in the development of the condition under consideration.
10067 the veteran has received long term eye therapy with topically applied drugs or solutions at some time.
10068 the veteran has received long term therapy with topically applied drugs or solutions to side and site of the body at some time. the long term therapy with topically applied drugs or solutions to side and site of the body was given for an illness or injury which is identifiable. 22047 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for conjunctivitis. 10071 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for the clinical onset of conjunctivitis. 10072 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and operational service for the clinical onset of conjunctivitis. or 10073 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and eligible service for the clinical onset of conjunctivitis. or 22048 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for the clinical worsening of conjunctivitis. 22049 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and operational service for the clinical worsening of conjunctivitis. or 22050 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and eligible service for the clinical worsening of conjunctivitis. Clinical onset and operational service [10072] 10074 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to operational service. Clinical onset and eligible service [10073] 10075 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to eligible service. Clinical worsening and operational service [22049] 10074 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to operational service. Clinical worsening and eligible service [22050] 10075 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to eligible service.